Abbott investigates two separate cyber incidents, says no operations affected

Abbott Laboratories disclosed it is investigating two cyber incidents involving unauthorized access to internal systems tied to its cancer diagnostics business and the LabCentral portal. The company stated operations were not affected, but the breach investigation raises near-term uncertainty around data security and potential remediation costs. Market impact is likely limited unless further details or patient/partner data impacts emerge.